No Priors · 2026-06-10 · 56 min
Biohub started with an ambitious goal of curing, preventing, and managing all disease by the end of the century. A decade later, thanks to the convergence of frontier AI and biological data, that goal may have been too conservative. In this episode, Elad Gil and Sarah Guo sit down with Biohub co-founders Mark Zuckerberg and Priscilla Chan, alongside Biohub Head of Science Alex Rives. Together, they discuss Biohub’s $500 million virtual biology initiative, which integrates frontier AI with wet-lab work to build predictive world models of cells, proteins, and systems. They also talk about their newly announced open-source engine for digital protein and antibody design, ESMFold2; why Biohub is a nonprofit rather than a venture-backed startup; and how hierarchical simulations will soon allow doctors to treat patients at an individual, mechanistic level.
Really Big Test-Time Compute in AI Changes Benchmarks, Safety and Research with OpenAI Research Scientist Noam Brown89 / 100
How Nuclear Will Unlock Energy Abundance with Valar Atomics Founder Isaiah Taylor
Re-engineering the Semiconductor Supply Chain with Intel CEO Lip-Bu Tan
We Need An Ecosystem in AI, And Every Company Can Win A Place In It
Building an AI Guardian for Enterprise with Onyx Security CEO Maxim Bar Kogan